not strange at all dude the company is debt free trading at less than 1/2 of its current cash even with a dead product the co is severely undervalued...we had a $35 pt LAST WEEK. Easy bounce here as pr in the next 1-2 weeks detailing a deal with cash strapped biotechs. Co could literally buy 10 struggling bios with that cash and they still have one product pre clin with potential. to all the peeps saying its gonna crash and die -> they're clearly new to trading. lol price floor in for now and looking to reset soon.
News 
Market Data 
Discover 
